118 related articles for article (PubMed ID: 16226335)
21. Clinical efficacy and safety of 6-thioguanine in the treatment of childhood acute lymphoblastic leukemia: A protocol for systematic review and meta-analysis.
Chen L; Yan HX; Liu XW; Chen WX
Medicine (Baltimore); 2020 May; 99(18):e20082. PubMed ID: 32358392
[TBL] [Abstract][Full Text] [Related]
22. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
[TBL] [Abstract][Full Text] [Related]
23. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
[TBL] [Abstract][Full Text] [Related]
24. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
de Boer NK; Reinisch W; Teml A; van Bodegraven AA; Schwab M; Lukas M; Ochsenkühn T; Petritsch W; Knoflach P; Almer S; van der Merwe SW; Herrlinger KR; Seiderer J; Vogelsang H; Mulder CJ;
Digestion; 2006; 73(1):25-31. PubMed ID: 16493198
[TBL] [Abstract][Full Text] [Related]
25. Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia.
Higgerson K; Flatt T
J Pediatr Hematol Oncol; 2023 May; 45(4):e514-e517. PubMed ID: 37027323
[TBL] [Abstract][Full Text] [Related]
26. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Kitchen BJ; Balis FM; Poplack DG; O'Brien M; Craig CE; Adamson PC
Clin Cancer Res; 1997 May; 3(5):713-7. PubMed ID: 9815740
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?
Gilissen LP; Derijks LJ; Driessen A; Bos LP; Hooymans PM; Stockbrügger RW; Engels LG
Dig Liver Dis; 2007 Feb; 39(2):156-9. PubMed ID: 17188950
[TBL] [Abstract][Full Text] [Related]
28. Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients.
van Asseldonk DP; Simsek M; de Boer NKH; Jharap B; Bloemena E; den Hartog G; Westerveld DB; Becx MC; Russel MG; Lissenberg-Witte BI; van Nieuwkerk CM; Mulder CJJ; Verheij J; van Bodegraven AA
Scand J Gastroenterol; 2019 Jun; 54(6):753-760. PubMed ID: 31203688
[No Abstract] [Full Text] [Related]
29. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
30. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
[No Abstract] [Full Text] [Related]
31. 6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations.
Lancaster DL; Patel N; Lennard L; Lilleyman JS
Br J Clin Pharmacol; 2001 Jun; 51(6):531-9. PubMed ID: 11422012
[TBL] [Abstract][Full Text] [Related]
32. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW
Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170
[TBL] [Abstract][Full Text] [Related]
33. Further experience with the use of 6-thioguanine in patients with Crohn's disease.
Ansari A; Elliott T; Fong F; Arenas-Hernandez M; Rottenberg G; Portmann B; Lucas S; Marinaki A; Sanderson J
Inflamm Bowel Dis; 2008 Oct; 14(10):1399-405. PubMed ID: 18521912
[TBL] [Abstract][Full Text] [Related]
34. Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.
Pavlidis P; Ansari A; Duley J; Oancea I; Florin T
Inflamm Bowel Dis; 2014 Dec; 20(12):2239-46. PubMed ID: 25230165
[TBL] [Abstract][Full Text] [Related]
35. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
[TBL] [Abstract][Full Text] [Related]
36. Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.
Meir H; Balawi I; Nayel H; El Karaksy H; El Haddad A
Med Pediatr Oncol; 2001 Apr; 36(4):469-73. PubMed ID: 11260570
[TBL] [Abstract][Full Text] [Related]
37. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
38. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
39. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
van Kooten Niekerk PB; Schmiegelow K; Schroeder H
Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
[TBL] [Abstract][Full Text] [Related]
40. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.
Dubinsky MC; Vasiliauskas EA; Singh H; Abreu MT; Papadakis KA; Tran T; Martin P; Vierling JM; Geller SA; Targan SR; Poordad FF
Gastroenterology; 2003 Aug; 125(2):298-303. PubMed ID: 12891528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
